Southeast Asian Brugada Syndrome Cohort
SEA-BrS
Discovering the Genetic Causes of Brugada Syndrome in Thais and Southeast Asian Population
1 other identifier
observational
750
1 country
11
Brief Summary
Brugada syndrome (BrS) is the leading cause of sudden death in young Asian adults including Thailand. This syndrome may be hereditary and involve mutations in certain genes. Aim of the study is to identify the relationship between genetic variants and the diagnosis/clinical severity of patients with BrS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 28, 2016
CompletedFirst Submitted
Initial submission to the registry
January 13, 2020
CompletedFirst Posted
Study publicly available on registry
January 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedJanuary 18, 2020
January 1, 2020
4.9 years
January 13, 2020
January 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relationship between genetic variants and Brugada syndrome (Brugada syndrome phenotype)
Case-Control study of genetic variants in BrS cases vs controls. Genetic study was done by whole genome sequencing and SNP array. Association analysis assessed by polygenic risk score and regression coefficients.
7 years
Secondary Outcomes (2)
Natural history of Brugada syndrome (survival from arrhythmic events)
7 years
Epidemiology of Brugada syndrome
7 years
Study Arms (2)
Case
Thai patients with diagnosed Brugada syndrome by confirmed Brugada type 1 ECG.
Control
Healthy volunteers without Brugada marker from ECG.
Eligibility Criteria
Thai Brugada syndrome patients and healthy volunteers
You may qualify if:
- Thai nationality
- The patient has at least one of confirmed Brugada type 1 ECG in at least one of right precordial leads (v1 or v2) with or without pharmacologic provocative testing. The confirmed ECG is standard 12 lead ECG or Brugada lead
You may not qualify if:
- The patient has other cardiac diseases such as ischemic heart disease, valvular heart disease, congenital heart disease, myocarditis and pericarditis
- The patient has type 2 or type 3 Brugada ECG without type 1 ECG during pharmacologic provocative testing and/or Brugada lead
- The patient had one time of Brugada type 1 ECG during drug use without reproducibility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Siriraj Hospital, Mahidol University
Bangkok Noi, Bangkok, 10700, Thailand
Vajira Hospital
Dusit, Bangkok, 10300, Thailand
Chulalongkorn University
Pathum Wan, Bangkok, 10330, Thailand
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Ratchathewi, Bangkok, 10400, Thailand
Bhumibol Adulyadej RTAF Hospital
Sai Mai, Bangkok, 10220, Thailand
Bumrungrad International Hospital
Vadhana, Bangkok, 10110, Thailand
Pacific Rim Electrophysiology Research Institute Data Coordinating Center
Vadhana, Bangkok, 10110, Thailand
Bangkok Hospital
Bangkok, 10310, Thailand
Faculty of Medicine, Chiang Mai University
Chiang Mai, 50200, Thailand
Queen Sirikit Heart Center of the Northeast
Khon Kaen, 40002, Thailand
Central Chest Hospital
Nonthaburi, 11000, Thailand
Related Publications (6)
Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation. 2012 Jan 31;125(4):620-37. doi: 10.1161/CIRCULATIONAHA.111.023838. No abstract available.
PMID: 22294707RESULTPriori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013 Dec;10(12):1932-63. doi: 10.1016/j.hrthm.2013.05.014. Epub 2013 Aug 30. No abstract available.
PMID: 24011539RESULTNademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupasawadikul S, Tatsanavivat P. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation. 1997 Oct 21;96(8):2595-600. doi: 10.1161/01.cir.96.8.2595.
PMID: 9355899RESULTBezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Borggrefe M, Schimpf R, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Olesen MS, Kaab S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R, Boukens BJ, Bezieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, Le Marec H, Wilde AA, Probst V, Schott JJ, Dina C, Redon R. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet. 2013 Sep;45(9):1044-9. doi: 10.1038/ng.2712. Epub 2013 Jul 21.
PMID: 23872634RESULTChimparlee N, Prechawat S, Khongphatthanayothin A, Mauleekoonphairoj J, Lekchuensakul S, Wongcharoen W, Makarawate P, Sahasatas D, Krittayaphong R, Amnueypol M, Anannab A, Ngarmukos T, Vardhanabhuti S, Sutjaporn B, Wandee P, Veerakul G, Bezzina CR, Poovorawan Y, Nademanee K. Clinical Characteristics of SCN5A p.R965C Carriers: A Common Founder Variant Predisposing to Brugada Syndrome in Thailand. Circ Genom Precis Med. 2021 Jun;14(3):e003229. doi: 10.1161/CIRCGEN.120.003229. Epub 2021 Jun 7. No abstract available.
PMID: 34092119DERIVEDMakarawate P, Glinge C, Khongphatthanayothin A, Walsh R, Mauleekoonphairoj J, Amnueypol M, Prechawat S, Wongcharoen W, Krittayaphong R, Anannab A, Lichtner P, Meitinger T, Tjong FVY, Lieve KVV, Amin AS, Sahasatas D, Ngarmukos T, Wichadakul D, Payungporn S, Sutjaporn B, Wandee P, Poovorawan Y, Tfelt-Hansen J, Tanck MWT, Tadros R, Wilde AAM, Bezzina CR, Veerakul G, Nademanee K. Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand. Heart Rhythm. 2020 Dec;17(12):2145-2153. doi: 10.1016/j.hrthm.2020.06.027. Epub 2020 Jun 30.
PMID: 32619740DERIVED
Related Links
Biospecimen
Whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Koonlawee Nademanee, MD
Chulalongkorn University
- STUDY DIRECTOR
Yong Poovorawan, MD
Chulalongkorn University
- PRINCIPAL INVESTIGATOR
Apichai Khongphatthanayothin, MD
Chulalongkorn University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics, Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine
Study Record Dates
First Submitted
January 13, 2020
First Posted
January 18, 2020
Study Start
January 28, 2016
Primary Completion
January 1, 2021
Study Completion
January 1, 2023
Last Updated
January 18, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will share
Medical journals, abstract submissions and results database